ITMCTR2100004898
Recruiting
Phase 1
Clinical study on the treatment of gastroesophageal reflux cough by the reverse embedding method of tongdu xuanfei
anjing Hospital of Traditional Chinese Medicine0 sitesTBD
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- anjing Hospital of Traditional Chinese Medicine
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Diagnostic criteria:
- •In this study, the relevant diagnostic criteria in the Guidelines for the Diagnosis and Treatment of Caughing (2015\) and the Guidelines for the Diagnosis and Management of gastroesophageal reflux disease were as follows:
- •(1\)Chronic cough, mainly in the daytime, worsened after eating, lasting for more than 8 weeks, and no obvious lesions on chest CT;
- •(2\)Coughing is related to eating, such as coughing after meals or eating;
- •(3\)Accompanied by acid reflux, belching, burning sensation behind the sternum and other symptoms;
- •(4\)The changes of reflux inflammation of esophagus were observed by endoscopy;
- •(5\)Cut\-variant asthma, eosinophilic bronchitis, postnasal drip syndrome and other diseases were excluded. Items (1\) and (5\) above, together with any of the other items, are required to be clinically diagnosed as GERC.
- •(1\)It meets the above diagnostic criteria;
- •(2\)Aged 18 to 70 years, gender is not limited;
- •(3\)No exposure history of COVID\-19 within 14 days;
Exclusion Criteria
- •1\.Complicated with irritable bowel syndrome and other diseases of the digestive system;
- •2\.Complicated tumor, mental disease, blood disease, serious infection, etc.;
- •3\.Complicated with heart, liver, kidney and other serious medical diseases;
- •4\.Unwilling to accept acupuncture treatment or have a history of needle sickness;
- •5\.People with a history of drug allergy;
- •6\.Severe anxiety, depression and obvious suicidal tendency;
- •7\.Pregnant or lactating women.
- •Any of the above items should be excluded.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
A fact-finding study on the treatment of gastroesophageal reflux disease (GERD) - Prospective study on therapeutic effects of proton pump inhibitors on reflux esophagitisJPRN-UMIN000005271GERD Society120
Completed
N/A
A fact-finding study on the treatment of gastroesophageal reflux disease (GERD) - Retrospective study on therapeutic effects of proton pump inhibitors on reflux esophagitisgastroesophageal reflux disease (GERD)JPRN-UMIN000005272GERD Society500
Completed
N/A
A fact-finding study on the treatment of gastroesophageal reflux disease (GERD) -Investigation of response to proton pump inhibitor (PPI) therapy and factors involvedJPRN-UMIN000006614GERD Society500
Recruiting
N/A
This is a study to find out whether the surgical procedure for weight loss affects the symptoms of acidity and vomitingsHealth Condition 1: null- Obesity, Gastro-oesophageal refluxCTRI/2013/03/003482All India Institute of Medical Sciences30
Active, Not Recruiting
N/A
Healing of patients suffering from gastroesophageal reflux esophagitisgrade C-D according to Los Angeles classification after treatment with pantoprazole-magnesium dihydrate 80 mg o.d. in comparison topantoprazole-sodium sesquihydrate 40 mg o.d. over 4 or 8 weeks - Magnum IIGastroesophageal reflux esophagitisMedDRA version: 5.0Level: lltClassification code 10038263EUCTR2004-000492-33-LTALTANA Pharma AG800